Standout Papers
Immediate Impact
4 from Science/Nature 56 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
2025 Standout
Works of Ye Zhou being referenced
Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial
2022
CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ye Zhou | 426 | 236 | 118 | 891 | 723 | 50 | 1.5k | |
| Yingqiang Shi | 594 | 248 | 327 | 1060 | 922 | 49 | 1.9k | |
| Pierre Rudolph | 320 | 166 | 601 | 614 | 332 | 42 | 1.4k | |
| Francesca Megiorni | 180 | 419 | 147 | 960 | 375 | 64 | 2.0k | |
| Takeshi Kusafuka | 195 | 85 | 288 | 644 | 210 | 66 | 1.4k | |
| Shinya Oda | 544 | 173 | 550 | 700 | 357 | 66 | 1.9k | |
| Isabella Morra | 176 | 170 | 291 | 407 | 291 | 42 | 1.2k | |
| Tingguo Zhang | 347 | 70 | 430 | 603 | 266 | 63 | 1.5k | |
| Wen‐Liang Fang | 443 | 108 | 276 | 660 | 640 | 61 | 1.4k | |
| Changqing Ma | 564 | 74 | 444 | 775 | 316 | 50 | 1.7k | |
| Veena Rajaram | 312 | 30 | 199 | 777 | 273 | 60 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...